Latest Recruitments & Recent News
See which life sciences companies have partnered with us to identify top candidates for their teams.
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group
The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology
The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics
Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
Aeglea BioTherapeutics Builds Rare Disease Clinical Development Team Through Partnership With The Chase Group, Inc.
The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals
Alexza Pharmaceuticals Continues Partnership With The Chase Group to Seek Clinical Operations Leader
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership With The Chase Group
The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs, for Akcea Therapeutics
Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group
The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics
Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
Akcea Therapeutics Retains The Chase Group to Secure Senior Vice President for Global Medical Affairs
A New Decade, A New Partnership, and Continued Growth for Alexza Pharmaceuticals and The Chase Group
Eisai, Inc. Cuts to the Chase for Their Recruiting Expertise in Global Medical Affairs, Oncology
Through Partnership With The Chase Group, Aeglea BioTherapeutics Continues Building Rare Disease Clinical Development Leadership Team
Aeglea BioTherapeutics (NASDAQ: AGLE) Partners with The Chase Group to Build Clinical Development Team for Rapidly Expanding Genetic Rare Disease Portfolio
The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals
